Design Therapeutics Inc.

DSGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.55

+$0.31 (+2.53%)

At close: Sep 21, 2026, 4:00 PM ET

$12.46

-$0.09 (-0.72%)

Pre-market: Sep 22, 2026, 4:45 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $764.47M

Enterprise Value $578.47M

Beta 1.66

Average Volume 842.59K

Shares Outstanding (Diluted) 62.51M

Shares Change YoY 9.93%

Institutional Ownership 61.83%

Exchange NASDAQ

ISIN US25056L1035

Price Performance

Price Change 1M -17.6%

Price Change 3M -8.7%

Price Change 6M 17.0%

Price Change YTD 37.9%

Price Change 1Y 97.6%

Price Change 3Y 422.9%

Price Change 5Y -21.3%

1M CAGR (ann.) -11.1%

1Y CAGR (ann.) 105.7%

5Y CAGR (ann.) -6.3%

All-Time CAGR -19.9%

Valuation

PE Ratio -10.64

Forward PE N/A

PEG Ratio 1.86

Forward PEG -0.59

PS Ratio N/A

Forward PS 3.80

PB Ratio 3.88

P/FCF Ratio -14.22

P/Adj. FCF Ratio -11.21

P/OCF Ratio -14.26

EV/Sales N/A

EV/EBIT -7.95

EV/EBITDA -8.00

EV/FCF -10.49

Earnings Yield -9.4%

FCF Yield -7.0%

Adj. FCF Yield -8.9%

Financial Health

Net Cash $207.4M

Total Debt $2.03M

Cash & Short-Term Investments $207.4M

Total Assets $215.13M

Current Ratio 18.86

Quick Ratio 18.86

Debt / Equity Ratio 0.01

Debt / EBITDA -0.03

Debt / FCF -0.04

OCF / Debt -27.12

Interest Coverage 0.00

Altman Z-Score 32.39

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -26.9%

Returns

Return on Assets -32.9%

Return on Equity -34.0%

Return on Invested Capital -38.9%

Return on Capital Employed -38.9%

Return on Tangible Assets -32.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -13.1%

EPS CAGR 5Y -4.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -3.5%

FCF CAGR 5Y -3.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y -12.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) -$0.38

EPS Growth Est (next Q) 26.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $20.50

Price Target Upside 63.3%

Cash Flow

Operating Cash Flow $-55.08M

Free Cash Flow $-55.14M

Adj. Free Cash Flow $-69.95M

FCF Per Share -$0.88

OCF Per Share -$0.88

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $1K

Operating Income $-79.36M

EBITDA $-72.34M

Net Income $-70.8M

EPS (Diluted) -$1.18

Revenue / Employee N/A

Profit / Employee $-1.29M

Employees 55